Clinical trial
Helicobacter Pylori Eradication With a New Sequential Treatment
NCT00132171 · IRCCS Azienda Ospedaliero-Universitaria di Bologna, Other · Completed
Key facts
| NCT number | NCT00132171 |
|---|---|
| Title | Helicobacter Pylori Eradication With a New Sequential Treatment |
| Official title | High Eradication Rates of Helicobacter Pylori With a New Sequential Treatment |
| Lead sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Helicobacter Pylori Infection, Non Ulcer Dyspepsia, Duodenal Ulcer, Gastric Ulcer, Chronic Active Gastritis, Gastritis |
| Intervention type | Drug |
| Interventions | Sequential therapy |
| Enrollment | 1,000 |
| Start date | Jan 1, 2001 |
| Completion | Dec 1, 2001 |
| First posted | Aug 19, 2005 |
| Last update posted | Mar 18, 2021 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: